Guía Farmacogeria./04 FINAL_cor - Sociedad Española de Médicos ...

PATOLOGÍA
Genitourinaria
BIBLIOGRAFÍA
1. Canadian Coordinating Office for Health Technology Assesement (CCOHTA).Treatments for prostatic
hypertrophy [en línea]. Ottawa: CCOHTA; 2003 (Pre assesemant nº17). Disponible en:
http://www.ccohta.ca/entry_e.html
2. Center for Diseases Control and Prevention. Sexually transmited diseases treatment guidelines.
[en línea] Atlanta GA: US Department of Health and Human Services, CDC; 2002 (MMWR Vol. 51
nº RR-6). Disponible en: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5106a1.htm
3. Hay-SmithJ, Herbison P, ellis G, Moore K.Anticholinergic drugs versus placebo for overactiva bladder
síndrome in adults (Cochrane Review). En:The Cochrane Library. Chichester, UK: John Wiley & Sons,
Ltd; 2002 (issue 4).
4. Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of
prostate cancer. N Engl J Med. 2003;349:213-22.
5. AUA Practice Guidelines Committee. AUA guideline on management of bening prostatic
hyperplasia (2003). Chapter 1: diagnosis and treatment recommendations. Journal of Urology.
2003;170:530-547.
6. Wilt T, Ishani A, Mac Donald R. Serenoa repens for benign prostatic hyperplasia (Cochrane Review).
En: The Cochrane Library. Chichester, UK: John Wiley & Sons, Ltd; 2003 (issue 1).
HIPERPLASIA BENIGNA DE PRÓSTATA / INCONTINENCIA URINARIA / BIBLIOGRAFÍA
70 / 71